Displaying 21 - 30 of 35 results
-
Medication Safety FactsheetReducing medication errors is the focus of a factsheet released today by the Health Quality & Safety Commission.
-
ALERT: Prescribing by weight in childrenThis alert was developed in response to a request by the Health and Disability Commissioner following a case where the dose of medicine for a baby was calculated using a weight recorded as being kilograms when it was actually pounds and ounces.
-
Patient information - Help us to help youA leaflet about medicines safety for patients coming into hospital.
-
Parent information - Help us to help your childA leaflet about medicines safety for the parents of children coming into hospital.
-
National medication chart toolkit, user guide and medication charting standard (updated February 2021)The medication charting toolkit has been prepared for health practitioners who are implementing the national medication chart and/or conducting education and training on how to use the national medication chart.
-
Some medicines for epilepsy, mental health, and pain can harm your unborn babyA booklet and a flyer from ACC with information for people who could get pregnant, and their families and whānau, understand the risks and benefits of taking anti-seizure medicines for epilepsy, mental health and pain.
-
Pain-relieving medicines for acute pain – information for patientsThe Health Quality & Safety Commission, Choosing Wisely and the Australian and New Zealand College of Anaesthetists have developed an information leaflet to help patients, caregivers and whānau use opioid medicines safely, to manage non-cancer pain.
-
Safe use of opioids data collection and reporting workbook (manual data capture)Spreadsheet template for manual data capture, for the safe use of opioids data collection and reporting.
-
Display of combination product medicines in electronic systemsGuidelines for the display of combination product medicines in electronic systems.
-
Safety Signal: Changes to the labelling of Bicillin LA®Following international practice, the name and strength description for Bicillin LA® has been changed. The expression of the name will now be benzathine benzylpenicillin tetrahydrate. The expression of product strength will now be 1,200,000 units/2.3